GRP logo
ISPOR Using 'Real World' Data in Coverage and Reimbursement Decisions

Using real-world data for coverage and payment decisions: The ISPOR real-world data task force report.

The citation for this report is:
Garrison Jr. LP, Neumann PJ, Erickson P, et al. Using real-world data for coverage and payment decisions: The ISPOR real-world data task force report. Value Health 2007;10:326-35.

Task Force Co-Chairs:
Peter Neumann ScD, Professor, Tufts University School of Medicine Director, Center for the Evaluation of Value and Risk in Health Institute for Clinical Research and Health Policy Studies, Boston, MA, USA
Lou Garrison PhD, Professor, Pharmaceutical Outcomes Research & Policy Program, Department of Pharmacy, University of Washington,
Seattle, WA, USA

Clinical Outcomes Working Group
Chair: Deborah Marshall PhD, Vice President, Global Health Economics and Outcomes, i3 Innovus, Burlington, ON, Canada
Leadership Group:
Marc Berger MD, Merck & Company Inc., West Point, PA, USA
Gurvaneet Randhawa MD, MPH, Center for Outcomes and Evidence (COE), Agency for Healthcare Research and Quality, Rockville, MD, USA
Bruce Carleton PhD, Pharmaceutical Outcomes Programme, Children's and Women's Health Centre of British Columbia,
Vancouver, BC, Canada
Anne Smith, Pharmaceutical Outcomes Programme, Children's and Women's Health Centre of British Columbia, Vancouver, BC, Canada

Economic Outcomes Working Group
Chair: Lou Garrison PhD, Pharmaceutical Outcomes Research & Policy Program, Department of Pharmacy, University of Washington,
Seattle, WA, USA
Leadership Group:
Jens Grueger PhD, Novartis Pharmaceuticals AG, Basel, Switzerland
Penny Mohr, US Center for Medicare and Medicaid Services, Baltimore, MD, USA
Les Noe RPh,Ovation Research Group, Highland Park, IL, USA
Bill Crown, i3 Innovus, Auburndale, MA, USA

Patient Reported Outcomes Working Group
Chair:
Penny Erickson PhD, O.L.G.A., State College, PA, USA
Leadership Group:
Jamie Banks PhD, Abt Associates, Lexington, MA, USA
Richard Chapman PhD, ValueMedics Research, Alexandria, VA, USA
Mary A. Cifaldi, Ph.D, RPh., MSHA, Abbott Laboratories, Abbott Park, IL, USA
Andreas Pleil PhD, Pfizer Inc., San Diego, CA, USA

Evidence of Hierarchy Working Group
Chair: Dan Mullins PhD, University of Maryland, School of Pharmacy, Baltimore, MD, USA
Leadership Group:
Joe Jackson PhD, Bristol-Myers Squibb, Princeton, NJ, USA
Phil Sarocco MSc, RPh, Boston Scientific, Natick, MA, USA
Jennifer Elson-Lafata PhD, Henry Ford Center for Health Services, Detroit, MI, USA

ISPOR Members’ Comments on Draft Report


ISPOR Good Practices For Outcomes Research Index